APOE, MAPT, and COMT and Parkinson’s disease susceptibility and cognitive symptom progression

BACKGROUND: Cognitive decline is well recognized in Parkinson's disease (PD) and a major concern for patients and caregivers. Apolipoprotein E (APOE), catechol-O-methyl transferase (COMT), and microtubule-associated protein tau (MAPT) are of interest related to their contributions to cognitive...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Parkinsons Dis
Main Authors: Paul, Kimberly C, Rausch, Rebecca, Creek, Michelle M, Sinsheimer, Janet S, Bronstein, Jeff M, Bordelon, Yvette, Ritz, Beate
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5927361/
https://ncbi.nlm.nih.gov/pubmed/27061069
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JPD-150762
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados